{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:06:14Z","timestamp":1789477574888,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2022\u20131G-4251"],"award-info":[{"award-number":["2022\u20131G-4251"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273654"],"award-info":[{"award-number":["82273654"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LTGY24H260007"],"award-info":[{"award-number":["LTGY24H260007"]}]},{"name":"Medical Health Science and Technology Project of Zhejiang Province","award":["2025KY1315"],"award-info":[{"award-number":["2025KY1315"]}]},{"name":"Cyrus Tang Foundation for Young Scholar 2022","award":["2022-B126"],"award-info":[{"award-number":["2022-B126"]}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202406010179"],"award-info":[{"award-number":["202406010179"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202406010169"],"award-info":[{"award-number":["202406010169"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12519-026-01084-9","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:51:46Z","timestamp":1787917906000},"page":"805-818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Waist-to-height ratio as a practical indicator for screening pediatric metabolic dysfunction-associated steatotic liver disease in diverse populations and genetic backgrounds"],"prefix":"10.1007","volume":"22","author":[{"given":"Yun-Fei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Wolters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jia","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enkar","family":"Nur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jia","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Po","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Yun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Chun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Hebestreit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Hui","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6990-6781","authenticated-orcid":false,"given":"Yi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"1084_CR1","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","volume":"80","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Paik JM, Stepanova M, Ong J, Alqahtani S, Henry L. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. J Hepatol. 2024;80:694\u2013701. https:\/\/doi.org\/10.1016\/j.jhep.2024.01.014.","journal-title":"J Hepatol"},{"key":"1084_CR2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.medj.2024.07.013","volume":"5","author":"F Jiang","year":"2024","unstructured":"Jiang F, Wang L, Ying H, Sun J, Zhao J, Lu Y, et al. Multisystem health comorbidity networks of metabolic dysfunction-associated steatotic liver disease. Med. 2024;5:1413\u201323.e3. https:\/\/doi.org\/10.1016\/j.medj.2024.07.013.","journal-title":"Med"},{"key":"1084_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.medj.2024.03.017","volume":"5","author":"L Zhang","year":"2024","unstructured":"Zhang L, El-Shabrawi M, Baur LA, Byrne CD, Targher G, Kehar M, et al. An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease. Med. 2024;5:797\u2013815.e2. https:\/\/doi.org\/10.1016\/j.medj.2024.03.017.","journal-title":"Med."},{"key":"1084_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/gutjnl-2023-331090","volume":"74","author":"NP Goyal","year":"2025","unstructured":"Goyal NP, Xanthakos S, Schwimmer JB. Metabolic dysfunction-associated steatotic liver disease in children. Gut. 2025;74:669\u201377. https:\/\/doi.org\/10.1136\/gutjnl-2023-331090.","journal-title":"Gut"},{"key":"1084_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/apt.17096","volume":"56","author":"J Li","year":"2000","unstructured":"Li J, Ha A, Rui F, Zou B, Yang H, Xue Q, et al. Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021. Aliment Pharmacol Ther. 2000;56:396\u2013406. https:\/\/doi.org\/10.1111\/apt.17096.","journal-title":"Aliment Pharmacol Ther"},{"key":"1084_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s12519-024-00814-1","volume":"20","author":"EJ Lee","year":"2024","unstructured":"Lee EJ, Choi M, Ahn SB, Yoo JJ, Kang SH, Cho Y, et al. Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis. World J Pediatr. 2024;20:569\u201380. https:\/\/doi.org\/10.1007\/s12519-024-00814-1.","journal-title":"World J Pediatr"},{"key":"1084_CR7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/HEP.0000000000001440","volume":"82","author":"P Hartmann","year":"2025","unstructured":"Hartmann P, Mouzaki M, Hassan S, Kehar M, Mysore KR, Mauney E, et al. Call to action\u2014Pediatric MASLD requires immediate attention to curb health crisis. Hepatology. 2025;82:1341\u201351. https:\/\/doi.org\/10.1097\/HEP.0000000000001440.","journal-title":"Hepatology"},{"key":"1084_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","volume":"16","author":"V Nobili","year":"2019","unstructured":"Nobili V, Alisi A, Valenti L, Miele L, Feldstein AE, Alkhouri N. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nat Rev Gastroenterol Hepatol. 2019;16:517\u201330. https:\/\/doi.org\/10.1038\/s41575-019-0169-z.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1084_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jhep.2025.04.035","volume":"83","author":"LA D\u00edaz","year":"2025","unstructured":"D\u00edaz LA, Alazawi W, Agrawal S, Arab JP, Arrese M, Idalsoaga F, et al. High inherited risk predicts age-associated increases in fibrosis in patients with MASLD. J Hepatol. 2025;83:849\u201359. https:\/\/doi.org\/10.1016\/j.jhep.2025.04.035.","journal-title":"J Hepatol"},{"key":"1084_CR10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera AV, Chaffin M, Aragam KG, Haas ME, Roselli C, Choi SH, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50:1219\u201324. https:\/\/doi.org\/10.1038\/s41588-018-0183-z.","journal-title":"Nat Genet"},{"key":"1084_CR11","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1038\/s41591-024-03284-0","volume":"30","author":"O Jamialahmadi","year":"2024","unstructured":"Jamialahmadi O, De Vincentis A, Tavaglione F, Malvestiti F, Li-Gao R, Mancina RM, et al. Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease. Nat Med. 2024;30:3614\u201323. https:\/\/doi.org\/10.1038\/s41591-024-03284-0.","journal-title":"Nat Med"},{"key":"1084_CR12","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1016\/j.cgh.2020.02.011","volume":"18","author":"BK Koo","year":"2020","unstructured":"Koo BK, Joo SK, Kim D, Lee S, Bae JM, Park JH, et al. Development and validation of a scoring system, based on genetic and clinical factors, to determine risk of steatohepatitis in Asian patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2020;18:2592\u20139.e10. https:\/\/doi.org\/10.1016\/j.cgh.2020.02.011.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1084_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020194","volume":"13","author":"S Subramanian","year":"2022","unstructured":"Subramanian S. The difference in the proportions of deleterious variations within and between populations influences the estimation of FST. Genes (Basel). 2022;13:194. https:\/\/doi.org\/10.3390\/genes13020194.","journal-title":"Genes (Basel)"},{"key":"1084_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101150","volume":"49","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang Y, Xing Y, Wolters M, Shi D, Zhang P, et al. Establish a noninvasive model to screen metabolic dysfunction-associated steatotic liver disease in children aged 6\u201314 years in China and its applications in high-obesity-risk countries and regions. Lancet Reg Health West Pac. 2024;49:101150. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101150.","journal-title":"Lancet Reg Health West Pac"},{"key":"1084_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jpeds.2021.11.042","volume":"242","author":"K Song","year":"2022","unstructured":"Song K, Park G, Lee HS, Lee M, Lee HI, Choi HS, et al. Comparison of the triglyceride glucose index and modified triglyceride glucose indices to predict nonalcoholic fatty liver disease in youths. J Pediatr. 2022;242:79\u201385.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2021.11.042.","journal-title":"J Pediatr"},{"key":"1084_CR16","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"MC Amato","year":"2010","unstructured":"Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33:920\u20132. https:\/\/doi.org\/10.2337\/dc09-1825.","journal-title":"Diabetes Care"},{"key":"1084_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3345\/kjp.2019.00248","volume":"62","author":"B \u00d6zcab\u0131","year":"2019","unstructured":"\u00d6zcab\u0131 B, Demirhan S, Akyol M, \u00d6zt\u00fcrkmen Akay H, G\u00fcven A. Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity. Korean J Pediatr. 2019;62:450\u20135. https:\/\/doi.org\/10.3345\/kjp.2019.00248.","journal-title":"Korean J Pediatr"},{"key":"1084_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Consortium TGP, Authors C, Auton A, Abecasis GR, Committee S, Altshuler DM, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374. https:\/\/doi.org\/10.1038\/nature15393.","journal-title":"Nature"},{"key":"1084_CR19","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"1990","unstructured":"Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 1990;403:2133\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8.","journal-title":"Lancet"},{"key":"1084_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02354-4","volume":"23","author":"Y Zhang","year":"1999","unstructured":"Zhang Y, Wang F, Tang J, Shen L, He J, Chen Y. Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999\u20132018. Cardiovasc Diabetol. 1999;23:262. https:\/\/doi.org\/10.1186\/s12933-024-02354-4.","journal-title":"Cardiovasc Diabetol"},{"key":"1084_CR21","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s00535-003-1178-8","volume":"38","author":"S Kojima","year":"2003","unstructured":"Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38:954\u201361. https:\/\/doi.org\/10.1007\/s00535-003-1178-8.","journal-title":"J Gastroenterol"},{"key":"1084_CR22","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003.","journal-title":"J Hepatol"},{"key":"1084_CR23","doi-asserted-by":"crossref","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555\u201376.","DOI":"10.1542\/peds.114.2.S2.555"},{"key":"1084_CR24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140:e20171904. https:\/\/doi.org\/10.1542\/peds.2017-1904.","journal-title":"Pediatrics"},{"key":"1084_CR25","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/hep4.1751","volume":"5","author":"J Wang","year":"2021","unstructured":"Wang J, Conti DV, Bogumil D, Sheng X, Noureddin M, Wilkens LR, et al. Association of genetic risk score with NAFLD in an ethnically diverse cohort. Hepatol Commun. 2021;5:1689\u2013703. https:\/\/doi.org\/10.1002\/hep4.1751.","journal-title":"Hepatol Commun"},{"key":"1084_CR26","doi-asserted-by":"publisher","first-page":"7855","DOI":"10.2147\/IJGM.S383261","volume":"15","author":"Y Wang","year":"2022","unstructured":"Wang Y, Huang X, Su Z, He J, Zhao N, Nie L, et al. The Glu69Asp polymorphism of EME1 gene is associated with an increased risk of hepatocellular carcinoma in Guangxi population, China. Int J Gen Med. 2022;15:7855\u201366. https:\/\/doi.org\/10.2147\/IJGM.S383261.","journal-title":"Int J Gen Med"},{"key":"1084_CR27","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41588-023-01497-6","volume":"55","author":"Y Chen","year":"2023","unstructured":"Chen Y, Du X, Kuppa A, Feitosa MF, Bielak LF, O\u2019Connell JR, et al. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease. Nat Genet. 2023;55:1640\u201350. https:\/\/doi.org\/10.1038\/s41588-023-01497-6.","journal-title":"Nat Genet"},{"key":"1084_CR28","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41586-022-05299-4","volume":"610","author":"B Chen","year":"2022","unstructured":"Chen B, Sun L, Zeng G, Shen Z, Wang K, Yin L, et al. Gut bacteria alleviate smoking-related NASH by degrading gut nicotine. Nature. 2022;610:562\u20138. https:\/\/doi.org\/10.1038\/s41586-022-05299-4.","journal-title":"Nature"},{"key":"1084_CR29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3760\/cma.j.cn501113-20220222-00084","volume":"31","author":"PP Zhang","year":"2023","unstructured":"Zhang PP, Song JY, Wang HJ, Wang H. Combined effect of PNPLA3 rs738409 and UGT1A1 rs10929303 gene polymorphisms on nonalcoholic fatty liver disease in children. Zhonghua Gan Zang Bing Za Zhi. 2023;31:723\u20138. https:\/\/doi.org\/10.3760\/cma.j.cn501113-20220222-00084.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"1084_CR30","doi-asserted-by":"publisher","unstructured":"Pozarickij A, Williams C, Guggenheim JA, and the UK Biobank Eye and Vision Consortium. Non-additive (dominance) effects of genetic variants associated with refractive error and myopia. Mol Genet Genom. 2020;295:843\u201353. https:\/\/doi.org\/10.1007\/s00438-020-01666-w.","DOI":"10.1007\/s00438-020-01666-w"},{"key":"1084_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100437","volume":"2","author":"N Ghodsian","year":"2021","unstructured":"Ghodsian N, Abner E, Emdin CA, Gobeil \u00c9, Taba N, Haas ME, et al. Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease. Cell Rep Med. 2021;2:100437. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100437.","journal-title":"Cell Rep Med"},{"key":"1084_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82625-2","volume":"11","author":"S Eydivandi","year":"2021","unstructured":"Eydivandi S, Roudbar MA, Karimi MO, Sahana G. Genomic scans for selective sweeps through haplotype homozygosity and allelic fixation in 14 indigenous sheep breeds from Middle East and South Asia. Sci Rep. 2021;11:2834. https:\/\/doi.org\/10.1038\/s41598-021-82625-2.","journal-title":"Sci Rep"},{"key":"1084_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-03011-0","volume":"24","author":"Y Wang","year":"2025","unstructured":"Wang Y, Huang DQ, Zhang P, Wang M, Wu Y, Nur E, et al. Plasma inflammatory proteome profiles identify MASLD among children with overweight or obesity. Cardiovasc Diabetol. 2025;24:450. https:\/\/doi.org\/10.1186\/s12933-025-03011-0.","journal-title":"Cardiovasc Diabetol"},{"key":"1084_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11061083","volume":"11","author":"N Perez-Diaz-del-Campo","year":"2021","unstructured":"Perez-Diaz-del-Campo N, Riezu-Boj JI, Marin-Alejandre BA, Monreal JI, Elorz M, Herrero JI, et al. Three different genetic risk scores based on fatty liver index, magnetic resonance imaging and lipidomic for a nutrigenetic personalized management of NAFLD: the fatty liver in obesity study. Diagnostics. 2021;11:1083. https:\/\/doi.org\/10.3390\/diagnostics11061083.","journal-title":"Diagnostics"},{"key":"1084_CR35","doi-asserted-by":"publisher","first-page":"e214375","DOI":"10.1001\/jamapediatrics.2021.4375","volume":"176","author":"Z Liu","year":"2022","unstructured":"Liu Z, Gao P, Gao AY, Lin Y, Feng XX, Zhang F, et al. Effectiveness of a multifaceted intervention for prevention of obesity in primary school children in China: a cluster randomized clinical trial. JAMA Pediatr. 2022;176:e214375. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.4375.","journal-title":"JAMA Pediatr"},{"key":"1084_CR36","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","volume":"54","author":"G Sveinbjornsson","year":"2022","unstructured":"Sveinbjornsson G, Ulfarsson MO, Thorolfsdottir RB, Jonsson BA, Einarsson E, Gunnlaugsson G, et al. Multiomics study of nonalcoholic fatty liver disease. Nat Genet. 2022;54:1652\u201363. https:\/\/doi.org\/10.1038\/s41588-022-01199-5.","journal-title":"Nat Genet"},{"key":"1084_CR37","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461\u20135. https:\/\/doi.org\/10.1038\/ng.257.","journal-title":"Nat Genet"},{"key":"1084_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.144079","volume":"5","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n J, Adiels M, Bj\u00f6rnson E, Matikainen N, S\u00f6derlund S, R\u00e4m\u00f6 J, et al. Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans. JCI Insight. 2020;5:e144079. https:\/\/doi.org\/10.1172\/jci.insight.144079.","journal-title":"JCI Insight"},{"key":"1084_CR39","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1111\/liv.12909","volume":"35","author":"JH Park","year":"2015","unstructured":"Park JH, Cho B, Kwon H, Prilutsky D, Yun JM, Choi HC, et al. I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease. Liver Int. 2015;35:2537\u201346. https:\/\/doi.org\/10.1111\/liv.12909.","journal-title":"Liver Int"},{"key":"1084_CR40","doi-asserted-by":"publisher","first-page":"E1125","DOI":"10.1210\/jc.2015-1587","volume":"100","author":"N Santoro","year":"2015","unstructured":"Santoro N, Caprio S, Pierpont B, Van Name M, Savoye M, Parks EJ. Hepatic de novo lipogenesis in obese youth is modulated by a common variant in the GCKR gene. J Clin Endocrinol Metab. 2015;100:E1125\u201332. https:\/\/doi.org\/10.1210\/jc.2015-1587.","journal-title":"J Clin Endocrinol Metab"},{"key":"1084_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1247611","volume":"14","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Ji G, Li M. Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD. Front Endocrinol. 2023;14:1247611. https:\/\/doi.org\/10.3389\/fendo.2023.1247611.","journal-title":"Front Endocrinol"},{"key":"1084_CR42","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3417","volume":"47","author":"S Buch","year":"2015","unstructured":"Buch S, Stickel F, Tr\u00e9po E, Way M, Herrmann A, Nischalke HD, et al. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nat Genet. 2015;47:1443\u20138. https:\/\/doi.org\/10.1038\/ng.3417.","journal-title":"Nat Genet"},{"key":"1084_CR43","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","volume":"150","author":"RM Mancina","year":"2016","unstructured":"Mancina RM, Dongiovanni P, Petta S, Pingitore P, Meroni M, Rametta R, et al. The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent. Gastroenterology. 2016;150:1219\u201330.e6. https:\/\/doi.org\/10.1053\/j.gastro.2016.01.032.","journal-title":"Gastroenterology"},{"key":"1084_CR44","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/gutjnl-2020-320853","volume":"70","author":"VR Thangapandi","year":"2021","unstructured":"Thangapandi VR, Knittelfelder O, Brosch M, Patsenker E, Vvedenskaya O, Buch S, et al. Loss of hepatic Mboat7 leads to liver fibrosis. Gut. 2021;70:940\u201350. https:\/\/doi.org\/10.1136\/gutjnl-2020-320853.","journal-title":"Gut"},{"key":"1084_CR45","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jhep.2012.12.003","volume":"58","author":"V Nobili","year":"2013","unstructured":"Nobili V, Svegliati-Baroni G, Alisi A, Miele L, Valenti L, Vajro P. A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol. 2013;58:1218\u201329. https:\/\/doi.org\/10.1016\/j.jhep.2012.12.003.","journal-title":"J Hepatol"},{"key":"1084_CR46","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1097\/HEP.0000000000001368","volume":"82","author":"SA Xanthakos","year":"2025","unstructured":"Xanthakos SA, Ibrahim SH, Adams K, Kohli R, Sathya P, Sundaram S, et al. AASLD practice statement on the evaluation and management of metabolic dysfunction\u2013associated steatotic liver disease in children. Hepatology. 2025;82:1352\u201394. https:\/\/doi.org\/10.1097\/HEP.0000000000001368.","journal-title":"Hepatology"},{"key":"1084_CR47","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.3350\/cmh.2022.0336","volume":"29","author":"S Zhang","year":"2023","unstructured":"Zhang S, Mak LY, Yuen MF, Seto WK. Screening strategy for non-alcoholic fatty liver disease. Clin Mol Hepatol. 2023;29:S103\u201322. https:\/\/doi.org\/10.3350\/cmh.2022.0336.","journal-title":"Clin Mol Hepatol"},{"key":"1084_CR48","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1007\/s00330-020-07245-2","volume":"31","author":"JH Runge","year":"2021","unstructured":"Runge JH, van Giessen J, Draijer LG, Deurloo EE, Smets AMJB, Benninga MA, et al. Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity. Eur Radiol. 2021;31:1588\u201396. https:\/\/doi.org\/10.1007\/s00330-020-07245-2.","journal-title":"Eur Radiol"},{"key":"1084_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1084_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40618-024-02419-x","volume":"48","author":"PJ Giraudi","year":"2025","unstructured":"Giraudi PJ, Pascut D, Banfi C, Ghilardi S, Tiribelli C, Bondesan A, et al. Serum proteome signatures associated with liver steatosis in adolescents with obesity. J Endocrinol Invest. 2025;48:213\u201325. https:\/\/doi.org\/10.1007\/s40618-024-02419-x.","journal-title":"J Endocrinol Invest"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-026-01084-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-026-01084-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-026-01084-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:21:07Z","timestamp":1789474867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-026-01084-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1084"],"URL":"https:\/\/doi.org\/10.1007\/s12519-026-01084-9","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Beijing study and Ningbo study received approval from the Ethics Committee of Review Board of Peking University Health Science Center (Approval No. 00001052\u201322018) and the Ethics Committee of Ningbo First Hospital (Approval No. 2021-R168), respectively. Written informed consent was obtained from the children and their parents prior to enrollment. Analyses based on the GBD, 1000G\u00a0Project, and NHANES datasets used publicly available de-identified data and therefore did not require additional ethical approval. The authors confirm that they are accountable for all aspects of the work including full data access, data integrity, and accuracy of data analysis.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}